nafronyl has been researched along with Arrhythmias, Cardiac in 1 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rey, JL | 1 |
| Quiret, JC | 1 |
| Gamain, J | 1 |
| Errasti, M | 1 |
1 other study available for nafronyl and Arrhythmias, Cardiac
| Article | Year |
|---|---|
[Status epilepticus and transient disorders of heart conduction induced by too fast intravenous infusion of naftidrofuryl].
Topics: Aged; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Electrocardiography; Electroencephalography | 1978 |